Clinical Trials

Clinical trials should be every patient's starting point when it comes to pancreatic cancer. Find out about trials that are available today, and the cutting-edge research available to patients.

136 Articles

Dr. Conan Kinsey
Research
April 6, 2023 • 4 Min

Taking a Look At FAK Inhibitors

Dr. Conan Kinsey is looking at how FAK inhibitors can make immunotherapy more effective in combination with chemotherapy.

molecule model made of silvery beads on a yellowish background
Research
April 3, 2023 • 2 Min

Comparing Chemotherapy Before with Chemotherapy After Pancreatic Cancer Surgery

Researchers are comparing effectiveness of chemotherapy before surgery (neoadjuvant) with chemotherapy after surgery (adjuvant).

lattice of molecules in green and red
Research
March 13, 2023 • 2 Min

A New Treatment for Progressive Metastatic Pancreatic Cancer

Researchers are testing a new drug for second-line therapy (after initial treatment stops working) in metastatic pancreatic cancer.

lab and hands in blue gloves working with a syringe.
Research
February 14, 2023 • 2 Min

Brain Cancer Vaccine for Metastatic PNET

Researchers are testing a vaccine for PNET that targets a protein that is very abundant in many neuroendocrine tumors.

Lets Win PC logo
Research
January 27, 2023 • 6 Min

Research Updates from ASCO GI 2023

Read the latest clinical trial and research updates from the 2023 ASCO GI meeting, including a review of genetic testing uptake.

yellow/orange and rust colored oxidation on metal
Research
January 19, 2023 • 2 Min

Targeting the Oxidation Pathway to Treat Advanced Pancreatic Cancer

Researchers are testing a new drug that targets the oxidation pathway in order to make standard chemotherapy more effective for stage IV pancreatic cancer.

pipette in the lab
Research
December 30, 2022 • 5 Min

A Year in Review: 2022 in Research

What progress was made in pancreatic treatment and screening? Learn about the major pancreatic cancer developments of 2022.

T lymphocyte in red on dark background
Research
December 21, 2022 • 2 Min

Testing a New Immunotherapy Combo in Advanced Pancreatic Cancer

Researchers are testing an approved immunotherapy drug with a new drug that works on T cells to make it more effective for pancreatic cancer.

Dr. Tanios Bekaii-Saab
Research
December 16, 2022 • 4 Min

NAPOLI-3 Trial Meets Primary Endpoint in Metastatic Disease

Dr. Tanios Bekaii-Saab explains the early positive results from the NAPOLI-3 clinical trial, testing the NALIRIFOX combination.

slide of pancreatic cells in bright colors
Research
October 4, 2022 • 2 Min

More Effective Radiotherapy for Advanced Pancreatic Cancer Patients

Researchers are testing a drug that penetrates the stroma, to make radiotherapy work better for advanced pancreatic cancer patients.

different foods in special containers against a blue background
Research
September 8, 2022 • 2 Min

Managing Metastatic Pancreatic Cancer with Chemotherapy and Diet

A new clinical trial looks at a special diet that tries to curb a patient’s metabolism to slow cancer growth during chemotherapy.

Dr. Elizabeth Jaffee
Research
July 27, 2022 • 5 Min

Report Highlights Potential of TCR Therapy

Read about the potential of TCR therapy, a technique used with success for one pancreatic cancer patient in a groundbreaking immunotherapy clinical trial.

pills in gray scale
Research
July 19, 2022 • 2 Min

Four-Drug Combination Tested in Metastatic Pancreatic Cancer

A clinical trial is testing a drug combination including a drug used for erectile dysfunction, a new drug, and two immunotherapy drugs.

Dr. Allyson Ocean
Research
June 6, 2022 • 5 Min

Surprising Clinical Trial Results in Pancreatic and Rectal Cancer

Let’s Win Scientific Advisory Board Chair Dr. Allyson Ocean explains the surprising clinical trial results in pancreatic and rectal cancers.

circular flashes of red yellow and green light against a black background
Research
May 26, 2022 • 3 Min

Chemotherapy-Radiation Combination for Pancreatic Cancer in the Liver

Can targeted radiation disrupt tumor growth in the liver of advanced pancreatic cancer patients with BRCA2 and PALB2 mutations?